Healthleap Raises $38M to Scale AI That Flags Undiagnosed Hospital Patients

Healthleap Raises $38M to Scale AI That Flags Undiagnosed Hospital Patients

Healthleap, a medical AI startup founded in South Africa in 2022, has closed $38 million in total funding across two rounds: an $8 million Seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform is commercially available now and operates in more than 50 hospitals, with plans to cover over 40 major health conditions and expand into outpatient and home care.

Announcement Details and New Technical Features

Healthleap was founded in South Africa in 2022 by siblings Jemima and Josiah Meyer. It began as a clinical nutrition tool for dietitians before evolving into a general-purpose platform that identifies hospitalized patients who may have conditions such as malnutrition or delirium that go undetected early. The core technical architecture processes two types of data-blocked: structured fields (labs, weights, vital signs) and written clinical notes that carry the most telling signals, such as loss of appetite, recent weight loss, muscle loss, and difficulty swallowing. The system extracts positive and negative signals for these clinical concepts at scale, then feeds them into risk models.

The system runs nightly, analyzing every adult inpatient's record, then writes a risk score into the care team's workflow each morning with a dashboard showing patient trends. The company expanded from 3 hospital partners to more than 50 over the past year, with revenue growing over 10x in the same period. At Penn Medicine's university hospital, the malnutrition program delivered $23.8 million in annual financial impact, including $6.3 million from additional reimbursements and $17.5 million from reduced length of stay. Research indicates that 20% to 50% of inpatients suffer from malnutrition, which is associated with longer hospital stays, impaired wound healing, infection, and higher morbidity and mortality rates.

Benchmark & Competitive Performance

Unlike traditional screening tools that rely solely on structured data, Healthleap integrates signals extracted from written clinical notes with structured data to build a more comprehensive risk profile. This hybrid approach allows the platform to capture nuanced indicators that structured fields alone would miss, such as subtle changes in appetite or mobility documented in physician notes. The company's outcomes-based pricing model, which contractually guarantees multiples of contract value, underscores its confidence in delivering measurable ROI. Every customer has achieved at least 5x hard ROI, with some cases exceeding 20x annually, demonstrating strong competitive performance against conventional methods.

Industry Impact & Enterprise Adoption

Healthleap's rapid adoption by leading U.S. hospitals—including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare—signals growing enterprise trust in AI-driven clinical decision support. The platform's ability to integrate with existing EHR systems and embed into care team workflows reduces friction and accelerates time-to-value. By focusing on high-impact conditions like malnutrition and delirium, Healthleap addresses significant cost drivers in hospital care, potentially saving millions annually per institution. The company's expansion plans include building programs for aspiration pneumonia, pressure ulcers, and heart failure readmission risk, with the ultimate goal of covering over 40 major health conditions. This positions Healthleap as a scalable solution for hospitals seeking to improve patient outcomes and financial performance simultaneously.

Conclusion

With $38 million in fresh capital and a proven track record of delivering substantial ROI, Healthleap is poised to transform how hospitals identify and manage undiagnosed conditions. Its AI platform, already deployed in over 50 hospitals, combines structured and unstructured data to flag at-risk patients, enabling earlier interventions and better outcomes. As the company expands its condition coverage and explores new care settings, it exemplifies the growing role of AI in driving both clinical and financial value in healthcare.

Media Source: TechCrunch AI | Fact Verification & Analysis: AI Tools Oasis